4-Chloroisobutyrylfentanyl

4-Chloroisobutyrylfentanyl

Chemical structure of 4-Chloroisobutyrylfentanyl

4-Chloroisobutyrylfentanyl is a synthetic opioid analgesic that is structurally related to fentanyl. It is part of a class of drugs known as fentanyl analogues, which have been developed for medical use but have also been associated with illicit drug use and opioid overdoses.

Chemical Structure and Properties

4-Chloroisobutyrylfentanyl is a derivative of fentanyl, characterized by the substitution of a chlorine atom at the para position of the phenethyl group. This modification can alter the pharmacological properties of the compound, potentially affecting its potency, duration of action, and affinity for the mu-opioid receptor.

The chemical formula for 4-Chloroisobutyrylfentanyl is C₁₅H₂₀ClNO, and it has a molecular weight of 265.78 g/mol. The presence of the chlorine atom is a distinguishing feature that can be identified using spectroscopy techniques such as mass spectrometry and nuclear magnetic resonance (NMR).

Pharmacology

As an opioid, 4-Chloroisobutyrylfentanyl acts primarily on the central nervous system by binding to the mu-opioid receptors. This interaction results in analgesic effects, as well as potential side effects such as respiratory depression, sedation, and euphoria. The potency of 4-Chloroisobutyrylfentanyl relative to fentanyl and other opioids is a subject of research, as small structural changes can significantly impact the drug's pharmacodynamics.

Medical Use and Regulation

While fentanyl and some of its analogues are used in medical settings for pain management, 4-Chloroisobutyrylfentanyl is not approved for medical use. Due to its potential for abuse and the risk of overdose, it is classified as a controlled substance in many jurisdictions. The regulation of fentanyl analogues is part of broader efforts to combat the opioid epidemic.

Illicit Use and Public Health Concerns

The illicit production and distribution of fentanyl analogues, including 4-Chloroisobutyrylfentanyl, pose significant challenges to public health. These substances are often sold on the black market, sometimes mixed with other drugs, leading to increased risk of overdose. Public health initiatives focus on harm reduction strategies, such as the distribution of naloxone, an opioid antagonist that can reverse the effects of an overdose.

Related pages

• Fentanyl
• Opioid epidemic
• Opioid receptor
• Naloxone

4-Chloroisobutyrylfentanyl

• 
  Structure of 4-Chloroisobutyrylfentanyl